UNSPSC 51472803: Chlorhexidine

This classification denotes an anti-infective agent with the molecular formula C22H30Cl2N10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R4KO0DY52L, chemically known as 2,4,11,13-tetraazatetradecanediimidamide, n,n-bis(4-chlorophenyl)-3,12-diimino- but generally known as chlorhexidine, which bears US NIH Compound Identifier 9552079. European Medicines Agency schedules Chlorhexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06181MIG.

UNSPSC 51472803 Chlorhexidine is a Commodity code covering antimicrobial and antiseptic agents supplied to state and local government facilities, procured primarily as consumable janitorial, operational, and pharmaceutical products for healthcare, public safety, and multi-jurisdictional cooperative purchasing arrangements. State and local governments buy chlorhexidine-containing products for fire and rescue operations, healthcare facilities, and other public agencies through both direct county procurement and multi-state cooperative purchasing vehicles. Issuing bodies include county boards of commissioners, state departments of administration overseeing cooperative purchasing alliances, and participating state and local government facilities across multiple jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant issuing channel that aggregates demand across multiple states and local entities.

Recent activity shows a mix of county-level janitorial and operational procurement and broader multi-state pharmaceutical sourcing. Hillsborough County Board of County Commissioners posted ITB2600319 on July 7, 2026 (due July 24, 2026) for consumable janitorial and operational supplies, estimated at $765,679.84 for one year, to service 47 fire stations across Hillsborough County, Florida. MMCAP issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and over-the-counter products distributed across participating state and local facilities in Minnesota, Oregon, and other member jurisdictions, with awarded vendors required to meet cGMP and DSCSA compliance and maintain relationships with authorized wholesalers including AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson. Geographic activity centers on Florida and the multi-state MMCAP region; contract terms span one to two years with no guaranteed minimum volumes.